Literature DB >> 17724811

Intestinal Kaposi's sarcoma may mimic gastrointestinal stromal tumor in HIV infection.

A Zoufaly1, S Schmiedel, A W Lohse, J van Lunzen.   

Abstract

Diffuse intestinal Kaposi's sarcoma shares macroscopic and histopathologic features with gastrointestinal stromal tumors. Correct diagnosis may pose a clinical challenge. We describe the case of a young HIV-1-infected African lady without advanced immunodeficiency, who presented with a diffuse spindle cell tumor of the gut. Initial diagnosis was of a gastrointestinal stromal tumor, based on endoscopy and histopathology. Further evaluation revealed evidence for human herpesvirus 8 (HHV8) and the diagnosis had to be changed to diffuse intestinal Kaposi's sarcoma. Antiretroviral triple therapy together with chemotherapy was commenced, and has led to the rapid remission of intestinal lesions. With a background of HIV infection, the presence of HHV8 as the causative agent of Kaposi's sarcoma should be determined, as distinct treatment is indicated.

Entities:  

Mesh:

Year:  2007        PMID: 17724811      PMCID: PMC4611588          DOI: 10.3748/wjg.v13.i33.4514

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

Review 1.  Kaposi's sarcoma.

Authors:  K Antman; Y Chang
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

Review 2.  A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy.

Authors:  Justin Stebbing; Adam Sanitt; Mark Nelson; Tom Powles; Brian Gazzard; Mark Bower
Journal:  Lancet       Date:  2006-05-06       Impact factor: 79.321

3.  AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee.

Authors:  S E Krown; M A Testa; J Huang
Journal:  J Clin Oncol       Date:  1997-09       Impact factor: 44.544

4.  C-Kit (CD117) expression in AIDS-related, classic, and African endemic Kaposi sarcoma.

Authors:  Liron Pantanowitz; Erich J Schwartz; Bruce J Dezube; Sabine Kohler; Ronald F Dorfman; Steven R Tahan
Journal:  Appl Immunohistochem Mol Morphol       Date:  2005-06

5.  Imatinib-induced regression of AIDS-related Kaposi's sarcoma.

Authors:  Henry B Koon; Glenn J Bubley; Liron Pantanowitz; David Masiello; Brad Smith; Katherine Crosby; Joann Proper; Will Weeden; Thomas E Miller; Pamela Chatis; Merrill J Egorin; Steven R Tahan; Bruce J Dezube
Journal:  J Clin Oncol       Date:  2004-11-30       Impact factor: 44.544

6.  Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor.

Authors:  Y M Zhang; S Bachmann; C Hemmer; J van Lunzen; A von Stemm; P Kern; M Dietrich; R Ziegler; R Waldherr; P P Nawroth
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

Review 7.  Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.

Authors:  Markku Miettinen; Mourad Majidi; Jerzy Lasota
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

8.  Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

Authors:  D W Northfelt; B J Dezube; J A Thommes; B J Miller; M A Fischl; A Friedman-Kien; L D Kaplan; C Du Mond; R D Mamelok; D H Henry
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544

9.  Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.

Authors:  V Martinez; E Caumes; L Gambotti; H Ittah; J-P Morini; J Deleuze; I Gorin; C Katlama; F Bricaire; N Dupin
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.